Long-term course of anti-factor VIII antibody in patients with hemophilia A at a single center

por Yoo, Ki Young, Joo, Sang Chun, Choi, Yong Mook
Publicado 2016

Immune tolerance induction in patients with severe hemophilia A with inhibitors

por Ryu, Ji Eun, Park, Young Shil, Yoo, Ki Young, Lee, Kyoo Duck, Choi, Yong-Mook
Publicado 2015

Safety and effectiveness of Rixubis in patients with hemophilia B: a real-world, prospective, postmarketing surveillance study in South Korea

por Choi, Eun Jin, Hwang, Tai ju, Choi, Yong Mook, Kim, Hugh Chul, Yoo, Myung Chul, Song, Haylee, Badejo, Kayode
Publicado 2020

Safety and Efficacy of B-domain Deleted Third Generation Recombinant Factor VIII (GreenGene F™) in Korean Patients with Hemophilia A: Data from a Post-marketing Surveillance Study...

por Kim, Soon Ki, Yoo, Ki Young, Lee, Kun Soo, Hwang, Taiju, Choi, Yong Mook, Choi, Eun Jin, Park, Sang Kyu
Publicado 2017

Efficacy of Tandem High-Dose Chemotherapy and Autologous Stem Cell Rescue in Patients Over 1 Year of Age with Stage 4 Neuroblastoma: The Korean Society of Pediatric Hematology-Onco...

por Sung, Ki Woong, Ahn, Hyo Seop, Cho, Bin, Choi, Yong-Mook, Chung, Nack Gyun, Hwang, Tai Ju, Im, Ho Joon, Jeong, Dae Chul, Kang, Hyoung Jin, Koo, Hong Hoe, Kook, Hoon, Kim, Hack Ki, Lyu, Chuhl Joo, Seo, Jong Jin, Shin, Hee Young, Yoo, Keon Hee, Won, Sung Chul, Lee, Kun Soo
Publicado 2010